Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)
Clinical trial NCT06687174 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06687174
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-31
- Primary completion
- 2026-06-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.